How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?

被引：5
|
作者：
Christoph Koenen
机构：
[1] Novo Nordisk A/S,
[2] Krogshøjvej 55,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2008年 / 4卷 / 10期
关键词：
D O I：
10.1038/ncpendmet0972
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E1 / E1
相关论文
共 50 条
  • [31] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Kabadi, Udaya M.
    CLINICAL DRUG INVESTIGATION, 2008, 28 (11) : 697 - 701
  • [32] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Udaya M. Kabadi
    Clinical Drug Investigation, 2008, 28 : 697 - 701
  • [33] Starting insulin for Type 2 diabetes with insulin glargine added to oral agents versus twice-daily premixed insulin alone
    Janka, HU
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    DIABETOLOGIA, 2004, 47 : A269 - A270
  • [34] Starting insulin for type 2 diabetes with insulin glargine added to oral agents vs twice-daily premixed insulin alone
    Janka, H
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    DIABETES, 2004, 53 : A130 - A130
  • [35] 7.2 Physical Health Status and Nocturnal Hypoglycemia with Insulin Degludec vs. Insulin Glargine: A 2-Year Trial in Insulin-Naïve Patients with Type 2 Diabetes (934-P)
    Helena W. Rodbard
    Bertrand Cariou
    Bernard Zinman
    Yehuda Handelsman
    Michael L. Wolden
    Azhar Rana
    Chantal Mathieu
    Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 98 - 99
  • [36] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Nechevska, L.
    Nechevski, M.
    Nechevska, E.
    Boskovski, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [37] Improved efficacy when insulin detemir is added to OADs in Indian subjects with type 2 diabetes
    Ambady, Ramachandran
    Kumar, Fiarish
    Annamalai, Sundaram
    Patel, Mayur
    Gupta, Sunil
    Venkatanarasimhachar, Srishyla M.
    DIABETES, 2006, 55 : A469 - A470
  • [38] Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study
    Martin Pfohl
    Jochen Seufert
    Anja Borck
    Peter Bramlage
    Thorsten Siegmund
    Diabetes Therapy, 2021, 12 : 733 - 747
  • [39] How to select and combine oral agents for patients with type 2 diabetes mellitus
    Chipkin, SR
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 4 - 13
  • [40] Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
    Hong, Eun-Gyoung
    Min, Kyung-Wan
    Lim, Jung Soo
    Ahn, Kyu-Jeung
    Ahn, Chul Woo
    Yu, Jae-Myung
    Kim, Hye Soon
    Kim, Hyun Jin
    Kim, Won
    Kim, Dong Han
    Jang, Hak Chul
    ADVANCES IN THERAPY, 2024, 41 (05) : 1795 - 1814
12345